Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Spikevax JN.1 COVID-19 mRNA Vaccine 0.1mg/ml dispersion for injection multidose vials (Moderna, Inc) |
| BNF code | 1404000ATBHAEBR |
| Virtual Medicinal Product | Generic Spikevax JN.1 COVID-19 mRNA Vaccine 0.1mg/ml dispersion for injection multidose vials |
| Name | Spikevax JN.1 COVID-19 mRNA Vaccine 0.1mg/ml dispersion for injection multidose vials |
| Abbreviated name | Spikevax JN.1 COVID-19 Vacc 0.1mg/ml inj md vials |
| Supplier | Moderna, Inc |
| Current licensing authority | Medicines - MHRA/EMA |
| Previous licensing authority | None |
| Reason for change of licensing authority | Licence Granted |
| Date of change of licensing authority | 17 Sep 2024 |
| EMA additional monitoring | ✓ |
| Parallel import | ✗ |
| Restrictions on availability | Restricted Availability |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Spikevax JN.1 COVID-19 mRNA Vaccine 0.1mg/ml dispersion for injection multidose vials (Moderna, Inc) 2.5 ml | |
| Spikevax JN.1 COVID-19 mRNA Vaccine 0.1mg/ml dispersion for injection multidose vials (Moderna, Inc) 25 ml 10 x 2.5ml vials | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.